Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2020

Lin LL, Lakomy DS, Chiao EY, Strother RM, Wirth M, Cesarman E, et al. Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming Barriers. JCO Glob Oncol. 2020;6:1134-1146.

Althoff MJ, Nayak RC, Hegde S, Wellendorf AM, Bohan B, Filippi M-, et al. Yap1-Scribble polarization is required for hematopoietic stem cell division and fate. Blood. 2020;136(16):1824-1836.

Bhargava HK, Leo P, Elliott R, Janowczyk A, Whitney J, Gupta S, et al. Computationally Derived Image Signature of Stromal Morphology Is Prognostic of Prostate Cancer Recurrence Following Prostatectomy in African American Patients. Clin Cancer Res. 2020;26(8):1915-1923.

Siddiqui MT. Serous cavity fluids: Momentum, molecules, markers… and more! Cancer Cytopathol. 2020;128(6):381-383.

Wang Q, Jia S, Wang D, Chen X, Kalvakolanu DV, Zheng H, et al. A Combination of BRD4 and HDAC3 Inhibitors Synergistically Suppresses Glioma Stem Cell Growth by Blocking GLI1/IL6/STAT3 Signaling Axis. Mol Cancer Ther. 2020;19(12):2542-2553.

Kloetgen A, Thandapani P, Ntziachristos P, Ghebrechristos Y, Nomikou S, Lazaris C, et al. Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia. Nat Genet. 2020;52(4):388-400.

Nicolau S, Tracy JA, Pisapia DJ, Tanji K, Milone M. : A distal myopathy with polyglucosan bodies. JIMD Rep. 2020;55(1):88-90.

Itkonen HM, Poulose N, Steele RE, Martin SE, Levine ZG, Duveau DY, et al. Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9. Mol Cancer Res. 2020;18(10):1512-1521.

Magro CM, Olson LC. Erratum to "Small cell lymphocytic variant of marginal zone lymphoma: A distinct form of marginal zone lymphoma derived from naïve B cells as a cutaneous counterpart to the naïve marginal zone lymphoma of splenic origin" [Ann. Diagn. Pathol. 34 (2018) 1. Ann Diagn Pathol. 2020;46:151460.

Dalton T, Doubrovina E, Pankov D, Reynolds R, Scholze H, Selvakumar A, et al. Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy. Blood. 2020;135(21):1870-1881.